BIELLO, FEDERICA
BIELLO, FEDERICA
100007 - Dipartimento di Medicina interna e specialità mediche
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer
2018-01-01 Tagliamento, M.; Genova, C.; Rijavec, E.; Rossi, G.; Biello, F.; Dal Bello, M. G.; Alama, A.; Coco, S.; Boccardo, S.; Grossi, F.
Afatinib for the treatment of non-small cell lung cancer
2015-01-01 Biello, F.; Maggioni, C.; Rijavec, E.; Genova, C.; Barletta, G.; Gualco, E.; Truini, A.; Coco, S.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Boccardo, F.; Grossi, F.
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
2019-01-01 Carbone, Federico; Grossi, Francesco; Bonaventura, Aldo; Vecchié, Alessandra; Minetti, Silvia; Bardi, Nicholas; Elia, Edoardo; Ansaldo, Anna Maria; Ferrara, Daniele; Rijavec, Erika; Dal Bello, Maria Giovanna; Biello, Federica; Rossi, Giovanni; Tagliamento, Marco; Alama, Angela; Coco, Simona; Spallarossa, Paolo; Dallegri, Franco; Genova, Carlo; Montecucco, Fabrizio
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine
2018-01-01 Tagliamento, M.; Rijavec, E.; Barletta, G.; Biello, F.; Rossi, G.; Grossi, F.; Genova, C.
Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy
2017-01-01 Coco, S.; Alama, A.; Vanni, I.; Fontana, V.; Genova, C.; Bello, M. G. D.; Truini, A.; Rijavec, E.; Biello, F.; Sini, C.; Burrafato, G.; Maggioni, C.; Barletta, G.; Grossi, F.
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced nonâsmall cell lung cancer:18F-FDG PET/CT study
2017-01-01 Morbelli, Silvia; Alama, Angela; Ferrarazzo, Giulia; Coco, Simona; Genova, Carlo; Rijavec, Erika; Bongioanni, Francesca; Biello, Federica; Dal Bello, Maria Giovanna; Barletta, Giulia; Massollo, Michela; Vanni, Irene; Piva, Roberta; Nieri, Alberto; Bauckneht, Matteo; Sambuceti, Gianmario; Grossi, Francesco
Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system
2014-01-01 Truini, A.; Alama, A.; Dal-Bello, M. G.; Coco, S.; Vanni, I.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Grossi, F.
Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab
2020-01-01 Rossi, Giovanni; Bauckneht, Matteo; Genova, Carlo; Rijavec, Erika; Biello, Federica; Mennella, Simone; Dal Bello, Maria Giovanna; Cittadini, Giuseppe; Bruzzi, Paolo; Piva, Roberta; Ceriani, Valentina; Sambuceti, Gianmario; Lopci, Egesta; Morbelli, Silvia; Grossi, Francesco
Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer
2021-01-01 Rijavec, E.; Genova, C.; Biello, F.; Rossi, G.; Indini, A.; Grossi, F.
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review
2022-01-01 Parisi, F.; Rossi, G.; Biello, F.; Tagliamento, M.; Barletta, G.; Zullo, L.; Cella, E.; Sacco, G.; Dellepiane, C.; Bennicelli, E.; Favero, D.; Alama, A.; Coco, S.; Marconi, S.; Zinoli, L.; Tanda, E. T.; Pronzato, P.; Rijavec, E.; Genova, C.
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab
2024-01-01 Genova, Carlo; Marconi, Silvia; Chiorino, Giovanna; Guana, Francesca; Ostano, Paola; Santamaria, Sara; Rossi, Giovanni; Vanni, Irene; Longo, Luca; Tagliamento, Marco; Zullo, Lodovica; Dal Bello, Maria Giovanna; Dellepiane, Chiara; Alama, Angela; Rijavec, Erika; Ludovini, Vienna; Barletta, Giulia; Passiglia, Francesco; Metro, Giulio; Baglivo, Sara; Chiari, Rita; Rivoltini, Licia; Biello, Federica; Baraibar, Iosune; Gil-Bazo, Ignacio; Novello, Silvia; Grossi, Francesco; Coco, Simona
Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy
2016-01-01 Biello, Federica; Burrafato, Giovanni; Rijavec, Erika; Genova, Carlo; Barletta, Giulia; Truini, Anna; Coco, Simona; Bello, Maria Giovanna Dal; Alama, Angela; Boccardo, Francesco; Grossi, Francesco
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study
2024-01-01 Albertelli, M; Rossi, G; Nazzari, E; Genova, C; Biello, F; Rijavec, E; Dal Bello, M G; Patti, L; Tagliamento, M; Barletta, G; Morabito, P; Boschetti, M; Dotto, A; Campana, D; Ferone, D; Grossi, F
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer
2017-01-01 Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Rossi, G.; Tagliamento, M.; Dal Bello, M. G.; Coco, S.; Vanni, I.; Boccardo, S.; Alama, A.; Grossi, F.
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer
2016-01-01 Genova, C.; Rijavec, E.; Biello, F.; Rossi, G.; Barletta, G.; Dal Bello, M. G.; Vanni, I.; Coco, S.; Alama, A.; Grossi, F.
Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus.
2019-01-01 Tagliamento, M; Grossi, F; Paolino, S; Rijavec, E; Genova, C; Rossi, G; Biello, F; De Maria, A
Novel approaches for the treatment of unresectable malignant pleural mesothelioma: A focus on immunotherapy and target therapy (Review)
2022-01-01 Rijavec, Erika; Biello, Federica; Barletta, Giulia; Dellepiane, Chiara; Genova, Carlo
Prognostic relevance of circulating tumor cells and circulating cell-free DNA association in metastatic non-small cell lung cancer treated with nivolumab
2019-01-01 Alama, A.; Coco, S.; Genova, C.; Rossi, G.; Fontana, V.; Tagliamento, M.; Dal Bello, M. G.; Rosa, A.; Boccardo, S.; Rijavec, E.; Biello, F.; Longo, L.; Cavalieri, Z.; Bruzzo, C.; Grossi, F.
Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy
2018-01-01 Grossi, F.; Genova, C.; Rijavec, E.; Barletta, G.; Biello, F.; Dal Bello, M. G.; Meyer, K.; Roder, J.; Roder, H.; Grigorieva, J.
Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer
2017-01-01 Genova, C.; Rossi, G.; Rijavec, E.; Biello, F.; Barletta, G.; Tagliamento, M.; Grossi, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Afatinib and Erlotinib in the treatment of squamous-cell lung cancer | 1-gen-2018 | Tagliamento, M.; Genova, C.; Rijavec, E.; Rossi, G.; Biello, F.; Dal Bello, M. G.; Alama, A.; Coco, S.; Boccardo, S.; Grossi, F. | |
| Afatinib for the treatment of non-small cell lung cancer | 1-gen-2015 | Biello, F.; Maggioni, C.; Rijavec, E.; Genova, C.; Barletta, G.; Gualco, E.; Truini, A.; Coco, S.; Dal Bello, M. G.; Vanni, I.; Alama, A.; Boccardo, F.; Grossi, F. | |
| Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer | 1-gen-2019 | Carbone, Federico; Grossi, Francesco; Bonaventura, Aldo; Vecchié, Alessandra; Minetti, Silvia; Bardi, Nicholas; Elia, Edoardo; Ansaldo, Anna Maria; Ferrara, Daniele; Rijavec, Erika; Dal Bello, Maria Giovanna; Biello, Federica; Rossi, Giovanni; Tagliamento, Marco; Alama, Angela; Coco, Simona; Spallarossa, Paolo; Dallegri, Franco; Genova, Carlo; Montecucco, Fabrizio | |
| CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine | 1-gen-2018 | Tagliamento, M.; Rijavec, E.; Barletta, G.; Biello, F.; Rossi, G.; Grossi, F.; Genova, C. | |
| Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy | 1-gen-2017 | Coco, S.; Alama, A.; Vanni, I.; Fontana, V.; Genova, C.; Bello, M. G. D.; Truini, A.; Rijavec, E.; Biello, F.; Sini, C.; Burrafato, G.; Maggioni, C.; Barletta, G.; Grossi, F. | |
| Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced nonâsmall cell lung cancer:18F-FDG PET/CT study | 1-gen-2017 | Morbelli, Silvia; Alama, Angela; Ferrarazzo, Giulia; Coco, Simona; Genova, Carlo; Rijavec, Erika; Bongioanni, Francesca; Biello, Federica; Dal Bello, Maria Giovanna; Barletta, Giulia; Massollo, Michela; Vanni, Irene; Piva, Roberta; Nieri, Alberto; Bauckneht, Matteo; Sambuceti, Gianmario; Grossi, Francesco | |
| Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system | 1-gen-2014 | Truini, A.; Alama, A.; Dal-Bello, M. G.; Coco, S.; Vanni, I.; Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Grossi, F. | |
| Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab | 1-gen-2020 | Rossi, Giovanni; Bauckneht, Matteo; Genova, Carlo; Rijavec, Erika; Biello, Federica; Mennella, Simone; Dal Bello, Maria Giovanna; Cittadini, Giuseppe; Bruzzi, Paolo; Piva, Roberta; Ceriani, Valentina; Sambuceti, Gianmario; Lopci, Egesta; Morbelli, Silvia; Grossi, Francesco | |
| Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer | 1-gen-2021 | Rijavec, E.; Genova, C.; Biello, F.; Rossi, G.; Indini, A.; Grossi, F. | |
| Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review | 1-gen-2022 | Parisi, F.; Rossi, G.; Biello, F.; Tagliamento, M.; Barletta, G.; Zullo, L.; Cella, E.; Sacco, G.; Dellepiane, C.; Bennicelli, E.; Favero, D.; Alama, A.; Coco, S.; Marconi, S.; Zinoli, L.; Tanda, E. T.; Pronzato, P.; Rijavec, E.; Genova, C. | |
| Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab | 1-gen-2024 | Genova, Carlo; Marconi, Silvia; Chiorino, Giovanna; Guana, Francesca; Ostano, Paola; Santamaria, Sara; Rossi, Giovanni; Vanni, Irene; Longo, Luca; Tagliamento, Marco; Zullo, Lodovica; Dal Bello, Maria Giovanna; Dellepiane, Chiara; Alama, Angela; Rijavec, Erika; Ludovini, Vienna; Barletta, Giulia; Passiglia, Francesco; Metro, Giulio; Baglivo, Sara; Chiari, Rita; Rivoltini, Licia; Biello, Federica; Baraibar, Iosune; Gil-Bazo, Ignacio; Novello, Silvia; Grossi, Francesco; Coco, Simona | |
| Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy | 1-gen-2016 | Biello, Federica; Burrafato, Giovanni; Rijavec, Erika; Genova, Carlo; Barletta, Giulia; Truini, Anna; Coco, Simona; Bello, Maria Giovanna Dal; Alama, Angela; Boccardo, Francesco; Grossi, Francesco | |
| Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study | 1-gen-2024 | Albertelli, M; Rossi, G; Nazzari, E; Genova, C; Biello, F; Rijavec, E; Dal Bello, M G; Patti, L; Tagliamento, M; Barletta, G; Morabito, P; Boschetti, M; Dotto, A; Campana, D; Ferone, D; Grossi, F | |
| Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer | 1-gen-2017 | Rijavec, E.; Genova, C.; Barletta, G.; Biello, F.; Rossi, G.; Tagliamento, M.; Dal Bello, M. G.; Coco, S.; Vanni, I.; Boccardo, S.; Alama, A.; Grossi, F. | |
| New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer | 1-gen-2016 | Genova, C.; Rijavec, E.; Biello, F.; Rossi, G.; Barletta, G.; Dal Bello, M. G.; Vanni, I.; Coco, S.; Alama, A.; Grossi, F. | |
| Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus. | 1-gen-2019 | Tagliamento, M; Grossi, F; Paolino, S; Rijavec, E; Genova, C; Rossi, G; Biello, F; De Maria, A | |
| Novel approaches for the treatment of unresectable malignant pleural mesothelioma: A focus on immunotherapy and target therapy (Review) | 1-gen-2022 | Rijavec, Erika; Biello, Federica; Barletta, Giulia; Dellepiane, Chiara; Genova, Carlo | |
| Prognostic relevance of circulating tumor cells and circulating cell-free DNA association in metastatic non-small cell lung cancer treated with nivolumab | 1-gen-2019 | Alama, A.; Coco, S.; Genova, C.; Rossi, G.; Fontana, V.; Tagliamento, M.; Dal Bello, M. G.; Rosa, A.; Boccardo, S.; Rijavec, E.; Biello, F.; Longo, L.; Cavalieri, Z.; Bruzzo, C.; Grossi, F. | |
| Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy | 1-gen-2018 | Grossi, F.; Genova, C.; Rijavec, E.; Barletta, G.; Biello, F.; Dal Bello, M. G.; Meyer, K.; Roder, J.; Roder, H.; Grigorieva, J. | |
| Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer | 1-gen-2017 | Genova, C.; Rossi, G.; Rijavec, E.; Biello, F.; Barletta, G.; Tagliamento, M.; Grossi, F. |